Marker Therapeutics Inc (MRKR)

Finanzdaten der Marker Therapeutics Inc-Aktie (MRKR)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	17.75% 1.2441	1.0565	0.2576	0.7627	4.7343
Operating Expenses	5.04% 3.7931	3.9943	3.4577	4.8967	9.7866
Benefits Costs and Expenses	4.12% 3.6369	3.793	3.2396	4.8616	9.7019
Costs And Expenses	4.12% 3.6369	3.793	3.2396	4.8616	9.7019
Operating Income/Loss	13.23% -2.549	-2.9378	-3.20	-4.1341	-5.0522
Income/Loss From Continuing Operations Before Tax	12.56% -2.3928	-2.7365	-2.982	-4.099	-4.9676
Income/Loss From Continuing Operations After Tax	12.67% -2.3928	-2.7401	-2.982	-4.099	-4.9676
Net Income/Loss	14.64% -2.3928	-2.8031	-2.982	2.5158	-4.9676
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	32,819% 8.902	0.027	8.8259	8.799	8.721
Diluted Average Shares	35,524% 8.902	-0.0251	8.8259	8.799	8.721
Basic Earnings Per Share	15.62% -0.27	-0.32	-0.34	0.29	-0.57
Diluted Earnings Per Share	15.62% -0.27	-0.32	-0.34	0.29	-0.57
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-